These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 22854890)

  • 1. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin.
    Hara M; Yamagata K; Tomino Y; Saito A; Hirayama Y; Ogasawara S; Kurosawa H; Sekine S; Yan K
    Diabetologia; 2012 Nov; 55(11):2913-9. PubMed ID: 22854890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of urinary podocalyxin in early diagnosis of diabetic nephropathy.
    Kostovska I; Trajkovska KT; Cekovska S; Topuzovska S; Kavrakova JB; Spasovski G; Kostovski O; Labudovic D
    Rom J Intern Med; 2020 Dec; 58(4):233-241. PubMed ID: 32780718
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes.
    Shoji M; Kobayashi K; Takemoto M; Sato Y; Yokote K
    Biomarkers; 2016; 21(2):164-7. PubMed ID: 26635084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli.
    Hara M; Yanagihara T; Hirayama Y; Ogasawara S; Kurosawa H; Sekine S; Kihara I
    Hum Pathol; 2010 Sep; 41(9):1265-75. PubMed ID: 20447677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
    Asao R; Asanuma K; Kodama F; Akiba-Takagi M; Nagai-Hosoe Y; Seki T; Takeda Y; Ohsawa I; Mano S; Matsuoka K; Kurosawa H; Ogasawara S; Hirayama Y; Sekine S; Horikoshi S; Hara M; Tomino Y
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1385-93. PubMed ID: 22700887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.
    Satirapoj B; Tassanasorn S; Charoenpitakchai M; Supasyndh O
    PLoS One; 2015; 10(4):e0124055. PubMed ID: 25884625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity.
    Suwanpen C; Nouanthong P; Jaruvongvanich V; Pongpirul K; Pongpirul WA; Leelahavanichkul A; Kanjanabuch T
    J Nephrol; 2016 Feb; 29(1):37-44. PubMed ID: 25905599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine markers of podocyte dysfunction: a review of podocalyxin and nephrin in selected glomerular diseases.
    Akankwasa G; Jianhua L; Guixue C; Changjuan A; Xiaosong Q
    Biomark Med; 2018 Aug; 12(8):927-935. PubMed ID: 29976076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
    Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
    J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary sediment podocalyxin in children with glomerular diseases.
    Kanno K; Kawachi H; Uchida Y; Hara M; Shimizu F; Uchiyama M
    Nephron Clin Pract; 2003; 95(3):c91-9. PubMed ID: 14646369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary podocalyxin as a possible novel marker of intrauterine nephrogenesis and extrauterine podocyte injury.
    Hayashi T; Tokuriki S; Okuno T; Ohta G; Igarashi A; Ohshima Y
    Pediatr Nephrol; 2017 Oct; 32(10):1891-1896. PubMed ID: 28439668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients].
    Ma RX; Zhao N; Zhang W
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):469-73. PubMed ID: 24059992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyturia parallels proximal tubule dysfunction in type 2 diabetes mellitus patients independently of albuminuria and renal function decline: A cross-sectional study.
    Petrica L; Vlad M; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Popescu R; Gluhovschi C; Matusz P; Velciov S; Bob F; Ursoniu S; Vlad D
    J Diabetes Complications; 2017 Sep; 31(9):1444-1450. PubMed ID: 28161386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury.
    Hara M; Yanagihara T; Kihara I; Higashi K; Fujimoto K; Kajita T
    J Am Soc Nephrol; 2005 Feb; 16(2):408-16. PubMed ID: 15625073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary podocyte-associated mRNA profile in Egyptian patients with diabetic nephropathy.
    Fayed A; Rahman Tohamy IA; Kahla H; Elsayed NM; El Ansary M; Saadi G
    Diabetes Metab Syndr; 2019; 13(5):2849-2854. PubMed ID: 31425946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research on the Combined Detection of Urine UmAlb and Urinary Nephrin, Podocalyxin in Podocyte of MKR Mice with Diabetic Nephropathy].
    Zeng J; Zhang X; Yu R; Tang Y; Luo WJ; Chen C; Wu YJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 46(5):722-5. PubMed ID: 26619543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Podocyte Count Detected by an Improved Immunocytochemical Method has Higher Diagnostic Efficiency than Enzyme-Linked Immunosorbent Assay and Serum Cystatin C to Evaluate the Early Stage Damage of Glomerular.
    Li L; Wang J; Li Y; Lu C; Liu Y; Zhang Z; Wang ZE; Zhang J; Lu Z
    J Clin Lab Anal; 2017 Mar; 31(2):. PubMed ID: 27435507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary podocyte and urinary podocalyxin; markers for diabetic nephropathy].
    Takemoto M; Shoji M; Yokote K
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():181-5. PubMed ID: 27266084
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis.
    Hara M; Yamamoto T; Yanagihara T; Takada T; Itoh M; Adachi Y; Yoshizumi A; Kawasaki K; Kihara I
    Nephron; 1995; 69(4):397-403. PubMed ID: 7777103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.
    Lioudaki E; Stylianou KG; Petrakis I; Kokologiannakis G; Passam A; Mikhailidis DP; Daphnis EK; Ganotakis ES
    Nephron; 2015; 131(1):34-42. PubMed ID: 26340089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.